Abstract
C19orf12 gene biallelic mutations lead mainly to neurodegeneration with brain iron accumulation-4. A 15-year-old male and his 17-year-old sister complained of cramps and exercise intolerance. Clinical examination of the boy mainly showed distal amyotrophy and mild weakness, while the sister predominantly had a tetrapyramidal syndrome. Widespread chronic neurogenic signs and hypointense signals on the striatum were present in both patients. Clinical exome sequencing identified, on both patients, the compound heterozygous pathogenic mutations c.204_214del p.(Gly69ArgfsTer10) and c.32C>T p.(Thr11Met). The description of these rare SPG43 and ALS-like phenotypes in the same family contributes to improve genotype-phenotype correlation in C19orf12-related diseases.
Data availability
Required data are stored and available upon request.
References
Meilleur KG, Traore M, Sangare M, Britton A, Landoure G, Coulibaly S, Niare B, Mochel F, La Pean A, Rafferty I, Watts C, Shriner D, Littleton-Kearney MT, Blackstone C, Singleton A, Fischbeck KH (2010) Hereditary spastic paraplegia and amyotrophy associated with a novel locus on chromosome 19. Neurogenetics 11(3):313–318. https://doi.org/10.1007/s10048-009-0230-0
Landoure G, Zhu PP, Lourenco CM, Johnson JO, Toro C, Bricceno KV, Rinaldi C, Meilleur KG, Sangare M, Diallo O, Pierson TM, Ishiura H, Tsuji S, Hein N, Fink JK, Stoll M, Nicholson G, Gonzalez MA, Speziani F, Durr A, Stevanin G, Biesecker LG, Center NIHIS, Accardi J, Landis DM, Gahl WA, Traynor BJ, Marques W Jr, Zuchner S, Blackstone C, Fischbeck KH, Burnett BG (2013) Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum Mutat 34(10):1357–1360. https://doi.org/10.1002/humu.22378
Deschauer M, Gaul C, Behrmann C, Prokisch H, Zierz S, Haack TB (2012) C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. J Neurol 259(11):2434–2439. https://doi.org/10.1007/s00415-012-6521-7
Hartig MB, Iuso A, Haack T, Kmiec T, Jurkiewicz E, Heim K, Roeber S, Tarabin V, Dusi S, Krajewska-Walasek M, Jozwiak S, Hempel M, Winkelmann J, Elstner M, Oexle K, Klopstock T, Mueller-Felber W, Gasser T, Trenkwalder C, Tiranti V, Kretzschmar H, Schmitz G, Strom TM, Meitinger T, Prokisch H (2011) Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet 89(4):543–550. https://doi.org/10.1016/j.ajhg.2011.09.007
Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ (2013) New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology 80(3):268–275. https://doi.org/10.1212/WNL.0b013e31827e07be
Gagliardi M, Annesi G, Lesca G, Broussolle E, Iannello G, Vaiti V, Gambardella A, Quattrone A (2015) C19orf12 gene mutations in patients with neurodegeneration with brain iron accumulation. Parkinsonism Relat Disord 21(7):813–816. https://doi.org/10.1016/j.parkreldis.2015.04.009
Olgiati S, Dogu O, Tufekcioglu Z, Diler Y, Saka E, Gultekin M, Kaleagasi H, Kuipers D, Graafland J, Breedveld GJ, Quadri M, Surmeli R, Sunter G, Dogan T, Yalcin AD, Bilgic B, Elibol B, Emre M, Hanagasi HA, Bonifati V (2017) The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Parkinsonism Relat Disord 39:64–70. https://doi.org/10.1016/j.parkreldis.2017.03.012
Schottmann G, Stenzel W, Lutzkendorf S, Schuelke M, Knierim E (2014) A novel frameshift mutation of C19ORF12 causes NBIA4 with cerebellar atrophy and manifests with severe peripheral motor axonal neuropathy. Clin Genet 85(3):290–292. https://doi.org/10.1111/cge.12137
Sparber P, Marakhonov A, Filatova A, Sharkova I, Skoblov M (2018) Novel case of neurodegeneration with brain iron accumulation 4 (NBIA4) caused by a pathogenic variant affecting splicing. Neurogenetics 19(4):257–260. https://doi.org/10.1007/s10048-018-0558-4
Monfrini E, Melzi V, Buongarzone G, Franco G, Ronchi D, Dilena R, Scola E, Vizziello P, Bordoni A, Bresolin N, Comi GP, Corti S, Di Fonzo A (2018) A de novo C19orf12 heterozygous mutation in a patient with MPAN. Parkinsonism Relat Disord 48:109–111. https://doi.org/10.1016/j.parkreldis.2017.12.025
Kruer MC, Salih MA, Mooney C, Alzahrani J, Elmalik SA, Kabiraj MM, Khan AO, Paudel R, Houlden H, Azzedine H, Alkuraya F (2014) C19orf12 mutation leads to a pallido-pyramidal syndrome. Gene 537(2):352–356. https://doi.org/10.1016/j.gene.2013.11.039
Dogu O, Krebs CE, Kaleagasi H, Demirtas Z, Oksuz N, Walker RH, Paisan-Ruiz C (2013) Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. Clin Genet 84(4):350–355. https://doi.org/10.1111/cge.12079
Gore E, Appleby BS, Cohen ML, DeBrosse SD, Leverenz JB, Miller BL, Siedlak SL, Zhu X, Lerner AJ (2016) Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN). Neurocase 22(5):476–483. https://doi.org/10.1080/13554794.2016.1247458
Schulte EC, Claussen MC, Jochim A, Haack T, Hartig M, Hempel M, Prokisch H, Haun-Junger U, Winkelmann J, Hemmer B, Forschler A, Ilg R (2013) Mitochondrial membrane protein associated neurodegeneration: a novel variant of neurodegeneration with brain iron accumulation. Mov Disord 28(2):224–227. https://doi.org/10.1002/mds.25256
Tschentscher A, Dekomien G, Ross S, Cremer K, Kukuk GM, Epplen JT, Hoffjan S (2015) Analysis of the C19orf12 and WDR45 genes in patients with neurodegeneration with brain iron accumulation. J Neurol Sci 349(1–2):105–109. https://doi.org/10.1016/j.jns.2014.12.036
Dezfouli MA, Alavi A, Rohani M, Rezvani M, Nekuie T, Klotzle B, Tonekaboni SH, Shahidi GA, Elahi E (2013) PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation. Mov Disord 28(2):228–232. https://doi.org/10.1002/mds.25271
Klysz B, Skowronska M, Kmiec T (2014) Mitochondrial protein associated neurodegeneration - case report. Neurol Neurochir Pol 48(1):81–84. https://doi.org/10.1016/j.pjnns.2013.09.002
Goldman JG, Eichenseer SR, Berry-Kravis E, Zimnowodzki S, Gregory A, Hogarth P, Hayflick SJ (2013) Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation. Mov Disord 28(10):1462–1463. https://doi.org/10.1002/mds.25410
Selikhova M, Fedotova E, Wiethoff S, Schottlaender LV, Klyushnikov S, Illarioshkin SN, Houlden H (2017) A 30-year history of MPAN case from Russia. Clin Neurol Neurosurg 159:111–113. https://doi.org/10.1016/j.clineuro.2017.05.025
Kasapkara CS, Tumer L, Gregory A, Ezgu F, Inci A, Derinkuyu BE, Fox R, Rogers C, Hayflick S (2019) A new NBIA patient from Turkey with homozygous C19ORF12 mutation. Acta Neurol Belg 119(4):623–625. https://doi.org/10.1007/s13760-018-1026-5
Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ (2019) Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Mol Genet Genomic Med 7(7):e00736. https://doi.org/10.1002/mgg3.736
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30
Association AP (2013) Attention-deficit/hyperactivity disorder. In: Association AP (ed) Diagnostic and statistical manual of mental disorders, Fifth Edition. Arlington, VA, p 59
Di Meo I, Tiranti V (2018) Classification and molecular pathogenesis of NBIA syndromes. Eur J Paediatr Neurol 22(2):272–284. https://doi.org/10.1016/j.ejpn.2018.01.008
https://www.phosphosite.org//proteinAction?id=4855191&showAllSites=true
Wang ZB, Liu JY, Xu XJ, Mao XY, Zhang W, Zhou HH, Liu ZQ (2019) Neurodegeneration with brain iron accumulation: insights into the mitochondria dysregulation. Biomed Pharmacother 118:109068. https://doi.org/10.1016/j.biopha.2019.109068
Arber CE, Li A, Houlden H, Wray S (2016) Review: insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories. Neuropathol Appl Neurobiol 42(3):220–241. https://doi.org/10.1111/nan.12242
Wiese M, Bannister AJ (2020) Two genomes, one cell: mitochondrial-nuclear coordination via epigenetic pathways. Mol Metab:100942. https://doi.org/10.1016/j.molmet.2020.01.006
Acknowledgments
Acknowledgments are given to the patients and their family to collaborate for the present study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Remiche, G., Vandernoot, I., Sadeghi-Meibodi, N. et al. SPG43 and ALS-like syndrome in the same family due to compound heterozygous mutations of the C19orf12 gene: a case description and brief review. Neurogenetics 22, 95–101 (2021). https://doi.org/10.1007/s10048-020-00631-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-020-00631-4